Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a bibliographic citation for the DREAMM-2 publication with full bibliographic details and identifiers, and updated the revision label to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page now includes related topic links for Multiple Myeloma and MedlinePlus Genetics, linking the study to disease-specific resources.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page no longer shows the disease label 'Multiple myeloma' and the 'related topics' section that included MedlinePlus Genetics. This removes disease-specific context and a related informational resource from the study details page.SummaryDifference0.1%

- Check29 days agoChange DetectedUpdated the page’s footer/version marker to a newer release and added entries under the “related topics” section (e.g., MedlinePlus Genetics). This reflects supplementary site metadata/navigation rather than substantive changes to the clinical trial information.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.